arrow_back Back Filing freshness 20-F FY 2013 SEC EDGAR

download Export Data

Fresenius Medical Care AG

FMS

$24.28 ▲ +0.18 (+0.75%) at close

8 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

Fresenius Medical Care AG shows strong fundamentals with top-quartile Profit Margin (%) and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $7.3B

Dividend Yield —

Revenue Growth —

Op. Margin 45.4%

ROIC 10.5% →

FCF / Share $4.26 ↘

Trailing P/E 6.7x

Price / Book 0.8x

FCF Yield 17.6%

Debt / Equity 0.85

info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$1.11B

↓ -6.5% —

FCF / Share Free cash flow per share

$4.26

↓ -5.9% —

Long-Term Debt Long-term obligations

$7.75B

— -0.5% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability

Returns ↓

Financial Health →

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2013 Dec 31, 2013 20-F ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗
EPS Growth YoY (%)	-6.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	9.9% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	8.9% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	8.7% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	8.7% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	13.2% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-6.5% Weak ↓ Weak Declining Year-over-year change in net income	10.8% Fair ↑ Fair Improving Year-over-year change in net income	9.5% Fair ↓ Fair Declining Year-over-year change in net income	9.8% Fair ↓ Fair Declining Year-over-year change in net income	9.0% Fair Fair Year-over-year change in net income	14.0% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%)	-5.9% Weak ↓ Weak Declining Year-over-year change in free cash flow	59.6% Excellent Excellent Year-over-year change in free cash flow	-0.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—
EPS CAGR 3Y (%)	3.9% Caution ↓ Caution Declining Compound annual EPS growth over 3 years	9.2% Fair → Fair Stable Compound annual EPS growth over 3 years	8.8% Fair Fair Compound annual EPS growth over 3 years	10.2% Good Good Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2013 Dec 31, 2013 20-F ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗
Operating Margin (%) (%)	45.4% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+203%)	—	—	—	—	—	—	—
Profit Margin (%) (%)	22.3% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+86%)	—	—	—	—	—	—	—
FCF Margin (%) (%)	25.9% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—
FCF / Net Income (x)	1.16x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2013 Dec 31, 2013 20-F ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗
Return on Invested Capital (%)	10.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	10.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	12.2% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	13.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	20.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	22.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	9.8% Fair ↓ Fair Declining Operating profit relative to total assets Optimal: > 10%	9.9% Fair ↓ Fair Declining Operating profit relative to total assets Optimal: > 10%	10.6% Good ↓ Good Declining Operating profit relative to total assets Optimal: > 10%	11.3% Good → Good Stable Operating profit relative to total assets Optimal: > 10%	11.1% Good Good Operating profit relative to total assets Optimal: > 10%	11.2% Good Good Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	12.0% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-20%)	13.3% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-12%)	13.6% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-10%)	13.3% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-12%)	13.1% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-13%)	13.7% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-9%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2013 Dec 31, 2013 20-F ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗
Debt to Equity (x)	0.85x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+42%)	0.88x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+47%)	0.71x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+18%)	0.68x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+13%)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.11x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-81%)	—	—
Interest Coverage (x)	5.04x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	4.72x Fair ↓ Fair Declining Operating income divided by interest expense Optimal: > 5x	5.82x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	6.30x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	5.46x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	4.63x Fair Fair Operating income divided by interest expense Optimal: > 5x	3.95x Fair Fair Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$7.16B	$7.22B	$5.14B	$4.46B	$15.12M	$461.57M	$-244.69M	$-159.01M
Debt / EBITDA (x)	2.70x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.80x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.13x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.05x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.14x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.33x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2013 Dec 31, 2013 20-F ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗
Revenue per Share (USD)	$16.46	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$3.65	$3.89	$3.54	$3.25	$2.99	$2.75	$2.43	—
Free Cash Flow per Share (USD)	$4.26	$4.53	$2.84	$2.85	—	—	—	—
Book Value per Share (USD)	$30.63	$29.70	$26.32	$24.86	$23.06	—	—	—
Tangible Book Value per Share (USD)	$-10.55	$-10.59	$-6.57	$-4.90	$-5.24	—	—	—
Basic Weighted Avg Shares (shares)	301.88M	301.14M	299.01M	296.81M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2013 Dec 31, 2013 20-F ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗
Working Capital (USD)	$2.73B	$2.96B	$1.43B	$1.36B	$2.12B	$1.07B	—	—
LT Debt (USD)	$7.75B	$7.79B	$5.49B	$4.31B	—	—	—	—
Total Equity (USD)	$9.23B	$8.94B	$7.90B	$7.38B	$6.82B	$5.96B	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2013 Dec 31, 2013 20-F ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗
Sales/Revenue/Turnover (USD)	$4.97B	—	—	—	—	—	—	—
Depreciation Expense (USD)	$648.23M	$602.90M	$557.28M	$503.22M	$457.08M	$415.67M	$363.33M	—
Net Income, GAAP (USD)	$1.11B	$1.19B	$1.07B	$978.52M	$891.14M	$817.61M	$717.13M	—
Operating Cash Flow (USD)	$2.03B	$2.04B	$1.45B	$1.37B	$1.34B	$1.02B	$1.20B	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 11 quarters

Fresenius Medical Care AG

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare FMS with peers